Victor Perlroth's most recent trade in Kodiak Sciences Inc was a trade of 600,000 shares done at an average price of $5.4 . Disclosure was reported to the exchange on Sept. 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.38 per share. | 25 Sep 2026 | 600,000 | 2,995,538 (6%) | 1% | 5.4 | 3,228,000 | - |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.49 per share. | 25 Sep 2026 | 365,840 | 3,361,378 (7%) | 0% | 2.5 | 910,942 | - |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 25 Sep 2026 | 314,684 | 3,676,062 (8%) | 0% | 4.0 | 1,243,002 | - |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | 15 Jul 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 25 Mar 2026 | 300,000 | 2,395,538 (5%) | 0% | 1.0 | 312,000 | Common Stock |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO | 25 Mar 2026 | 300,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 25 Mar 2026 | 300,000 | 2,395,538 (5%) | 0% | 1.0 | 312,000 | - |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO | 18 Mar 2026 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO | 31 Dec 2025 | 12,500 | 2,095,538 (4%) | 0% | 0 | Common Stock | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO | 31 Dec 2025 | 12,500 | 2,095,538 (4%) | 0% | 0 | - | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | 04 Jul 2025 | 340,000 | 340,000 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | 05 Aug 2024 | 406,000 | 406,000 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | 24 Jun 2023 | 335,000 | 335,000 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 60,000 | 3,448,038 (7%) | 0% | 0 | Common Stock | |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | 06 Jul 2022 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | ||
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.20 per share. | 24 Feb 2022 | 1,000,000 | 2,508,038 (5%) | 2% | 9.2 | 9,201,700 | Common Stock |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.99 per share. | 24 Feb 2022 | 340,000 | 2,168,038 (4%) | 0% | 9.0 | 3,055,988 | Common Stock |
| Kodiak Sciences Inc | Dr. Victor Perlroth, M.D. | Director, Chairman and CEO, Ten Percent Owner | 16 Feb 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) |